Telehealth for Oral Health in Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new telehealth program designed to help cancer survivors improve their oral health. The study compares two groups: one receives regular dental care information, while the other participates in virtual sessions (Telehealth Intervention, or THI) to enhance oral health knowledge and habits. The focus is on preventing mouth problems related to past cancer treatments and improving overall oral health. Eligible participants are cancer survivors who completed their primary treatment at least six months ago and have a smartphone. As an unphased trial, this study provides a unique opportunity to enhance oral health through innovative telehealth solutions.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this Telehealth Intervention is safe for cancer survivors?
Research has shown that telehealth for dental care, particularly for cancer patients, is generally well-liked. In one study, 78% of patients preferred this method. Furthermore, 92% of patients would recommend video consultations to others, indicating a positive experience with few side effects.
Other studies indicate that teledentistry not only improves health outcomes but also increases patient satisfaction. Patients report greater happiness with their care and communication with health providers. No major reports of negative side effects or safety issues have emerged with telehealth for dental care.
Overall, telehealth for oral health in cancer survivors appears safe and well-accepted.12345Why are researchers excited about this trial?
Researchers are excited about the Telehealth Intervention for oral health in cancer survivors because it offers a novel approach to managing oral health through virtual platforms. Unlike traditional methods that rely on in-person visits, this intervention allows participants to engage in virtual sessions, increasing accessibility and convenience. It also incorporates motivational interviewing techniques to boost oral health literacy and self-efficacy, which could empower patients to take better care of their oral health. This approach not only aims to improve oral hygiene but also fosters long-term healthy habits, which is particularly beneficial for cancer survivors who may face ongoing health challenges.
What evidence suggests that the Telehealth Intervention (THI) is effective for improving oral health in cancer survivors?
Research shows that telehealth services can greatly improve oral health. Studies have found that digital health programs for cancer patients help catch oral health problems early, improve mouth function, and enhance oral hygiene. For example, one study found that people using digital health tools had better mouth-opening and jaw function. Additionally, teledentistry has been linked to less plaque and gum disease, along with higher patient satisfaction. In this trial, the Telehealth Intervention (THI) arm will explore whether these benefits can effectively prevent oral health issues in cancer survivors.13678
Are You a Good Fit for This Trial?
This trial is for cancer survivors aged 25-75, from any racial or ethnic group, who have completed their primary cancer therapy at least 6 months ago. Participants must own a smartphone to be eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Intraoral imaging and collection of baseline saliva and blood samples
Treatment
Participants engage in a 6-month Telehealth Intervention (THI) or receive Usual Care (UC)
Follow-up
Participants are monitored for oral and systemic health outcomes post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Telehealth Intervention (THI)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgetown University
Lead Sponsor